Moleculin Biotech (NASDAQ:MBRX) Receives New Coverage from Analysts at StockNews.com
StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a report published on Wednesday morning. The brokerage issued a sell rating on the stock. Moleculin Biotech Stock Performance Shares of Moleculin Biotech stock opened at $0.61 on Wednesday. The business’s 50 day moving average price is $0.51 and its 200 day […]
More Stories
Citizens Financial Group Inc. RI Has $1.64 Million Stake in Vanguard Short-Term Corporate Bond ETF (NASDAQ:VCSH)
Citizens Financial Group Inc. RI reduced its stake in shares of Vanguard Short-Term Corporate Bond ETF (NASDAQ:VCSH – Free Report)...
FRP Holdings, Inc. (NASDAQ:FRPH) President Sells $78,750.00 in Stock
FRP Holdings, Inc. (NASDAQ:FRPH – Get Free Report) President David H. Devilliers, Jr. sold 2,500 shares of the company’s stock...
Commerce Bank Grows Holdings in Cardinal Health, Inc. (NYSE:CAH)
Commerce Bank increased its stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 0.5% in the third quarter, Holdings...
MaxLinear, Inc. (NASDAQ:MXL) Shares Sold by Jennison Associates LLC
Jennison Associates LLC cut its position in MaxLinear, Inc. (NASDAQ:MXL – Free Report) by 2.0% in the third quarter, according...
Sezzle (NASDAQ:SEZL) Trading Up 7% Following Insider Buying Activity
Sezzle Inc. (NASDAQ:SEZL – Get Free Report) shares traded up 7% on Thursday after an insider bought additional shares in...
Alphatec Holdings, Inc. (NASDAQ:ATEC) Shares Sold by King Luther Capital Management Corp
King Luther Capital Management Corp lessened its holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 27.4% during the...